Francisco J. Moreno

First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors:  Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2002 · 443 citations · Full text

Cytotoxicity and morphological effects induced by carvacrol and thymol on the human cell line Caco-2

María Llana‐Ruíz‐Cabello, Daniel Gutiérrez‐Praena, Silvia Pichardo et al. · Food and Chemical Toxicology · 2013 · 149 citations

Molecular Pharmacology, Morphological Effects, Medicine +2

SAR and 3D-QSAR Studies on Thiadiazolidinone Derivatives:  Exploration of Structural Requirements for Glycogen Synthase Kinase 3 Inhibitors

Ana Martı́nez, Mercedes Alonso, Ana Castro et al. · Journal of Medicinal Chemistry · 2005 · 127 citations · Full text

Drug Target, Bioorganic Chemistry, Chemical Biology +16

Thienyl and Phenyl α-Halomethyl Ketones:  New Inhibitors of Glycogen Synthase Kinase (GSK-3β) from a Library of Compound Searching

Santiago Conde, Daniel I. Pérez, Ana Martı́nez et al. · Journal of Medicinal Chemistry · 2003 · 99 citations · Full text

Lead Compounds, Glycobiology, Compound Searching +18

Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau

Ismael Santa‐María, Félix Hernández, Joaquín del Río Fernández et al. · Molecular Neurodegeneration · 2007 · 83 citations · Full text

Neurochemical Biomarkers, Cytoskeleton, Tau Aggregation +21